喧闹
发表于 2025-3-26 21:31:01
Frost, Drought, and Heat ResistanceNearly 17 million people in the U.S. are living with cancer [.]—survivorship has markedly improved in the past decades, highlighting the importance of effective strategies to surveil cancer complications in this population.
万灵丹
发表于 2025-3-27 02:57:54
http://reply.papertrans.cn/17/1643/164283/164283_32.png
青石板
发表于 2025-3-27 05:54:53
http://reply.papertrans.cn/17/1643/164283/164283_33.png
alliance
发表于 2025-3-27 10:50:08
Anthracycline/Trastuzumab Cardiac Toxicity,Anthracycline and Trastuzumab are the two most common cancer agents associated with chemotherapy-related cardiac dysfunction (CTRCD). This chapters aims to discuss the latest definitions of CTRCD, the mechanisms and treatment of CTRCD, as well as the role of multi-modal cardiac imaging in Anthracycline and trastuzuamb cardiotoxicity.
KEGEL
发表于 2025-3-27 16:50:31
http://reply.papertrans.cn/17/1643/164283/164283_35.png
visceral-fat
发表于 2025-3-27 20:13:54
http://reply.papertrans.cn/17/1643/164283/164283_36.png
browbeat
发表于 2025-3-27 22:33:57
http://reply.papertrans.cn/17/1643/164283/164283_37.png
善辩
发表于 2025-3-28 02:19:25
Vascular Toxicity of Tyrosine Kinase Inhibitors: Coronary Artery Disease,An older man with chest pain while receiving dasatinib and ruxolitinib.
Meager
发表于 2025-3-28 08:42:45
Vascular Toxicity of Tyrosine Kinase Inhibitors: Pulmonary Hypertension,A 41-year-old woman was diagnosed with CML and treated in the first-line setting with dasatinib, a second-generation BCR-ABL TKI. After 2 years of treatment, she achieved a major molecular response but reported new dyspnea on exertion.
配置
发表于 2025-3-28 11:50:13
http://reply.papertrans.cn/17/1643/164283/164283_40.png